Executive SummaryCam Garner to president and CEO of the San Diego-based R&D firm. Former topside Gordon Ramseier will assume the newly created position of vice chairman. Garner remains president of Dura Pharmaceuticals, an allergy products firm which was acquired by Immunetech in December ("The Pink Sheet" Feb. 5, T&G-13).
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.